LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.15 | 17.25 | 1035 | 5061 | 0.2045 | 0.6479 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.15 | 17.25 | 1054 | 5061 | 0.2083 | 0.6516 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.15 | 17.25 | 1372 | 5061 | 0.2711 | 0.7056 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.15 | 17.25 | 1409 | 5061 | 0.2784 | 0.7111 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.12 | 17.25 | 1046 | 5095 | 0.2053 | 0.6491 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.12 | 17.25 | 1061 | 5095 | 0.2082 | 0.6519 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.12 | 17.25 | 1387 | 5095 | 0.2722 | 0.7068 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 65.12 | 17.25 | 1422 | 5095 | 0.2791 | 0.7119 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.09 | 17.25 | 1066 | 5221 | 0.2042 | 0.6493 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.09 | 17.25 | 1080 | 5221 | 0.2069 | 0.6519 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.09 | 17.25 | 1389 | 5221 | 0.2660 | 0.7032 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.09 | 17.25 | 1426 | 5221 | 0.2731 | 0.7086 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.06 | 17.25 | 1065 | 5242 | 0.2031 | 0.6485 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.06 | 17.25 | 1080 | 5242 | 0.2060 | 0.6513 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.06 | 17.25 | 1369 | 5242 | 0.2611 | 0.6995 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.06 | 17.25 | 1399 | 5242 | 0.2669 | 0.7040 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.03 | 17.25 | 1079 | 5367 | 0.2010 | 0.6478 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.03 | 17.25 | 1095 | 5367 | 0.2040 | 0.6507 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.03 | 17.25 | 1422 | 5367 | 0.2650 | 0.7036 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.03 | 17.25 | 1444 | 5367 | 0.2691 | 0.7068 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.00 | 17.25 | 1081 | 5546 | 0.1949 | 0.6435 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.00 | 17.25 | 1098 | 5546 | 0.1980 | 0.6465 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.00 | 17.25 | 1417 | 5546 | 0.2555 | 0.6977 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.00 | 17.25 | 1438 | 5546 | 0.2593 | 0.7007 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.97 | 17.25 | 1087 | 5618 | 0.1935 | 0.6427 | MN20160310_N02 | C04 |